Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine
Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine
Loading...
Files
Publication or External Link
Date
2019-12-02
Advisor
Citation
Blue, T.R., Gordon, M.S., Schwartz, R.P. et al. Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine. Addict Sci Clin Pract 14, 45 (2019).
DRUM DOI
Abstract
It has been estimated that approximately 15% of people who are incarcerated in the US have histories of opioid use disorder. Relapse to opioid use after release from prison poses a serious risk of HIV infection. Prison-initiated buprenorphine may help to reduce HIV infection given the association between opioid use and HIV-risk behaviors.